about
Identification and comparative analysis of hepatitis C virus-host cell protein interactionsVariation in hepatitis C services may lead to inequity of heath-care provision: a survey of the organisation and delivery of services in the United KingdomMagnetic Resonance Elastography and Other Magnetic Resonance Imaging Techniques in Chronic Liver Disease: Current Status and Future Directions.Hepatitis C Recurrence after Orthotopic Liver Transplantation: Mechanisms and ManagementHepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antiviralsSteatosis and hepatitis CMagnetic resonance elastography of liver: technique, analysis, and clinical applications.Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis CSTEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis CGene expression and hepatitis C virus infectionPathogenesis of Hepatitis C Virus Infection in Tupaia belangeriUse of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B VirusA brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation.Evaluating progression of liver disease from repeat liver biopsies in children with chronic hepatitis C: a retrospective study.Mechanisms and significance of liver steatosis in hepatitis C virus infectionRelationship between the severity of hepatitis C virus-related liver disease and the presence of Helicobacter species in the liver: a prospective study.Influence of iron on the severity of hepatic fibrosis in patients with chronic hepatitis C.Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis CInterferon-related genetic markers of necroinflammatory activity in chronic hepatitis CEffectiveness of treatment with pegylated interferon and ribavirin in an unselected population of patients with chronic hepatitis C: a Danish nationwide cohort study.Detection of novel biomarkers of liver cirrhosis by proteomic analysis.Predicting clinical outcomes using baseline and follow-up laboratory data from the hepatitis C long-term treatment against cirrhosis trial.Coinfection with hepatitis C virus, oxidative stress and antioxidant status in HIV-positive drug users in Miami.Managing HCV infection in pediatric age group: suggested recommendations.Liver stiffness measurement among patients with chronic hepatitis B and C: results from a 5-year prospective study.LecT-Hepa facilitates estimating treatment outcome during interferon therapy in chronic hepatitis C patients.Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection.Characterization of hepatitis C Virus genotype 3a hypervariable region 1 in patients achieved rapid virological response to alpha interferon and ribavirin combination therapy.Activated hepatic stellate cells express keratinocyte growth factor in chronic liver diseaseImpact of treatment against hepatitis C virus on overall survival of naive patients with advanced liver diseaseNoninvasive biomarkers FibroTest and ActiTest versus liver biopsy in chronic hepatitis C patients: the Middle East experience.IFI35, mir-99a and HCV genotype to predict sustained virological response to pegylated-interferon plus ribavirin in chronic hepatitis C.Assessment of hepatic fibrosis in pediatric cases with hepatitis C virus in Egypt.Fibrosis progression in chronic hepatitis C virus infection.Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy.Review article: the evolving role of liver biopsy.Assessment of disease progression in patients with transfusion-associated chronic hepatitis C using transient elastography.Gene expression profiling of HCV genotype 3a initial liver fibrosis and cirrhosis patients using microarrayThe impact of host factors on management of hepatitis C virus.
P2860
Q24338554-0179F51F-30E2-40E5-8352-1E2E2E070982Q25256731-EC9CB02C-5C47-4CA1-81DA-60918064B896Q26738871-82623B7C-C3E1-4353-8A16-E96CB8640CBDQ26781984-0986550B-1F77-43ED-ABC2-170C6DAE07D7Q26782033-4A7393B4-CF97-495E-8678-A8CFA7C9F56BQ26798101-30383FCE-D392-4669-B9A3-87EF7F1281FEQ27027849-2D442446-F63D-4E2F-8C77-094D6F716C1BQ27477966-CAB9DC13-C9AE-4647-8131-60F293383A18Q27478329-5B1774B3-B7C8-4C5E-9739-D99DA447A7E6Q27482028-8EFABD3C-044C-4BEC-84EB-B6F3B33A9DD8Q27488345-28BF62F8-F205-4A6D-B3B2-4C7CDD98F9F0Q27490544-EB69EA37-0293-412A-9D20-122D5877C721Q30375738-C2DC6344-A6F5-43A8-9D8D-D874B5C33498Q30476922-FFB261BF-632D-4654-BB7E-562440D941CBQ33862153-B4C5C6BD-CE98-48F5-888A-980E45804F63Q33866272-520D345B-2076-4638-9ABB-330291F6DF6AQ33866459-D95ADAC4-DD39-4734-B05C-F6E578E837D1Q33867064-DDAFE02A-88D7-4FA4-8CC0-A53B1B0AEFC9Q33887760-61F1DFEF-69B4-4801-BC50-5A0BE511677FQ33898567-C3991997-6E85-472F-9936-2445A1013F2AQ33938574-68267034-2565-4728-9620-783F74E4FA72Q33954802-753EACA4-46BA-4326-A447-196AF81B4513Q34064042-287B06F9-8469-470B-A992-D9C167610AB3Q34279897-44F531DC-251A-454A-8FA3-103D0B35C20BQ34411942-A4609DBE-C5FD-43E0-8C34-6FFB0593763DQ34450720-AA20DEEE-6C48-4593-9C2C-E3DB406708D4Q34769512-8B2236AF-B157-472C-A87C-39B872C32616Q35010511-760DCD83-3987-4FE5-AAC0-61EB599F38F3Q35053127-299FF90B-8B38-444E-A361-955B32FEC60DQ35103291-34D07669-3996-491E-A446-CFC728602068Q35105799-16BA6CBC-BB00-4681-8C19-18087437D04CQ35199268-D6C7EDCE-091A-4881-917A-1F5DA22B4E53Q35284740-9D0E5D93-1C36-4F24-B7D8-DB9C63E396BFQ35397221-58CE9122-0492-4BFF-94E9-0286228AFDC1Q35666213-327161EC-3392-4216-9FA3-7BA8E8DC8922Q35761351-CB4D9ABA-2EAB-4925-A5B8-5494AD6A18D2Q35845834-6404922D-CC16-41D4-B483-DF5D277A23D0Q35872121-07FE2361-E024-46ED-9ACE-AAF6A1A287CBQ35945962-D559B287-C40A-4227-AE1B-7A18865C2B68Q35990066-3B2987A8-FDC9-410E-855E-B7DABD814A40
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Fibrosis and disease progression in hepatitis C.
@ast
Fibrosis and disease progression in hepatitis C.
@en
Fibrosis and disease progression in hepatitis C.
@nl
type
label
Fibrosis and disease progression in hepatitis C.
@ast
Fibrosis and disease progression in hepatitis C.
@en
Fibrosis and disease progression in hepatitis C.
@nl
prefLabel
Fibrosis and disease progression in hepatitis C.
@ast
Fibrosis and disease progression in hepatitis C.
@en
Fibrosis and disease progression in hepatitis C.
@nl
P2093
P2860
P356
P1433
P1476
Fibrosis and disease progression in hepatitis C.
@en
P2093
Nathalie Boyer
Patrick Marcellin
Tarik Asselah
P2860
P304
P356
10.1053/JHEP.2002.36993
P407
P433
P577
2002-11-01T00:00:00Z